News & Trends - MedTech & Diagnostics
How medtech is tackling the supply chain challenges: Cardinal Health MD
MedTech News: COVID-19 has exposed the weaknesses in the global supply chain and most businesses are still grappling with disruptions two years later.
Jane Crowe, Managing Director ANZ, Cardinal Health joined Health Industry Hub to reflect on the evolution of the supply chain environment and where the greatest risks lie currently. She discussed the related inflation pressures impacting medtechs as companies operate in a highly competitive market.
Jane also shared her perspectives on the impact of the supply chain disruptions on patient care and how Cardinal Health is navigating hospital and clinician expectations on cost and inventory issues. There are key factors to be considered in shaping a supply chain ecosystem that is fit-for-purpose.
Lastly, the COVID-19 pandemic has been “a master class in leadership”. Jane discussed the greatest leadership lessons and how these traits should be learned and adopted by managers and the wider workforce.
News & Trends - Biotechnology
AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm
Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]
MoreNews & Trends - MedTech & Diagnostics
Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis
MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]
MoreNews & Trends - MedTech & Diagnostics
Cardiac device benefits face more cuts, while technical services remain secure in the short term
MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]
MoreNews & Trends - Biotechnology
CSL’s world-first gene therapy heads for MSAC evaluation
Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]
More